The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
If you look at the trades this morning over 90% have been buys while the mm's have gradually reduced the price. This says one thing to me, they are obviously trying to clear the last of the CLN's. When they are cleared we should have blue sky.
A video from Steve Larratt which was posted on the Telegram board:
https://www.youtube.com/watch?v=wSh_Impm83M
It is because prices are going up that having a signed contract is so important. A contract should secure the price at the time it was signed. This I am reading as good news ,not the bad news that certain people are trying to say.
goza172/Gazza4563
This bulletin board isn't supposed to be all about your petty arguments with each other, it should be about EME. In my view the potential news could be significant and hence the slow but steady recent rise in the share price. Once the survey has been completed the share price could move ahead again and beyond the 7.5p sticking point.
The current daily supply of almost 900,000 lateral flow tests in the UK is not enough to meet demand, the chief executive of the Association of Independent Multiple Pharmacies Leyla Hannbeck has said.
She urged the government to improve the consistency of deliveries.
She told the BBC’s Today Programme:
It just simply isn’t enough to meet the demand and it’s patchy. Some days you get one box delivered and other days none. It isn’t enough for the pharmacies to deliver to the patients.
We want to make sure that the message is clear to the government that the supply needs to be consistent. People can get it easily from pharmacies if the supply is consistent.
The UK Health Security Agency has said there are now nearly 900,000 test kits being supplied per day - which is double the delivery capacity seen before December 18.